April 6, 2011 / 2:36 PM / 8 years ago

MIT Enterprise Forum of Cambridge Presents a Keynote Address by Chris Viehbacher, CEO of Sanofi-aventis

  CAMBRIDGE, MA, Apr 06 (MARKET WIRE) -- 
On April 11, the MIT Enterprise Forum of Cambridge will feature a keynote
by Chris Viehbacher, CEO of Sanofi-aventis. Headquartered in Paris,
France, Sanofi-aventis is the world's fourth largest pharmaceutical
company based on prescription sales. Sanofi-aventis recently acquired
Cambridge-based biotechnology company, Genzyme, for $20 billion. This is
the first public speaking engagement in Massachusetts for Mr. Viehbacher
since the transaction closed. 

    Following Mr. Viehbacher's keynote address, Dr. Jeffrey Elton, CEO and
co-founder of KEW Group LLC, a personalized oncology company, will
moderate a distinguished panel of industry experts including Dr. Ronald
DePinho of Dana-Farber Cancer Institute; Dr. Deborah Dunsire, President
and CEO of Millennium: the Takeda Oncology Company; Todd Foley, Managing
Director at MPM Capital; and Dr. Christoph Westphal, Chairman and
co-founder of Verastem, Founding Partner of Longwood Founders Fund, and
President of SR One. The discussion will be focused on the challenges of
funding and accelerating biomedical innovations today and the impact of
current and pending regulatory and reimbursement changes on the types of
innovations we need to advance.

    Click here for speaker biographies. 

    Keynote Speaker: 

    Chris Viehbacher is the CEO of Sanofi-aventis. Mr. Viehbacher is also the
Chairman of the Board of Directors of PhRMA (United States), Vice
Chairman of EFPIA (Belgium), Member of the Board of Directors of Research
America (United States) and Burroughs Wellcome Fund (United States),
Member of the Board of Visitors of Fuqua School of Business, Duke
University (United States), and Member of the Board of Business
Roundtable (United States). In his previous position, Mr. Viehbacher was
President, Pharmaceutical Operations North America, a member of the board
and Co-Chairman of the Portfolio Management Board. He is a graduate of
the Queens University (Ontario - Canada) and a certified public
accountant.

    Program Organizers: 


--  Pearl Freier is the President of Cambridge BioPartners,
--  Dr. Dana Gordon is the deputy chair of the intellectual property group
    at Foley Hoag LLP and a partner in the firm.

    

The event is sponsored by Foley Hoag LLP.

When:
 Monday, April 11,
2011
 5:30-6:00pm: Event registration and snacks
 6:10-8:00pm: Keynote
and panel
 8:00-9:00pm: Networking reception with food and drinks in the
R&D Pub

    Where: MIT Stata Center (Building 32), Room 123, 32 Vassar St.,
Cambridge, MA 

    Registration and information:
http://www.mitforumcambridge.org/events/innovation-series-event-featuring-chris-
iehbacher-chief-executive-officer-sanofi-aventis/


    Pricing: Forum members: $25, Non-members: $45. Students from all
universities are free with college ID. Pre-registration is encouraged.

    

MIT ENTERPRISE FORUM OF CAMBRIDGE CONTACT:
Trish Fleming
MIT Enterprise Forum of Cambridge
617-253-8240
trishf@mit.edu

PRESS CONTACT:
Maggie Roth (for MIT Enterprise Forum) 
CHEN PR, Inc. 
781-672-3145
mroth@chenpr.com 

Copyright 2011, Market Wire, All rights reserved.

-0-
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below